The overseer, In venture with various operational counterparts within the company and with external suppliers/vendors, Will ensure therapeutic strategy development and the clinical and operational enactment of company sponsored studies, private eye initiated studies and post marketing risk management research programs, because of in sourced, Outsourced or matrixed associations. the person will focus on Phase II Phase IV studies, Post marketing risk management research programs and IIS trials to ensure strategic level plans are executed in a timely and compliant fashion for achievement of Medical Affairs' research goals. Manage and be the cause of budgets for multiple therapeutic areas across the portfolio.

on the